Published in Arq Bras Endocrinol Metabol on March 01, 2009
Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet (2010) 3.02
Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. Nat Genet (2012) 2.02
An interleukin-6 gene promoter polymorphism is associated with polycystic ovary syndrome in South Indian women. J Assist Reprod Genet (2013) 0.89
Prevalence of metabolic syndrome is higher among non-obese PCOS women with hyperandrogenism and menstrual irregularity in Korea. PLoS One (2014) 0.85
Metabolic disorders in menopause. Prz Menopauzalny (2015) 0.85
Aberrant expression of long noncoding RNAs in cumulus cells isolated from PCOS patients. J Assist Reprod Genet (2015) 0.78
Importance of lipid accumulation product index as a marker of CVD risk in PCOS women. Lipids Health Dis (2015) 0.77
Systematic Evaluation of Genetic Variants for Polycystic Ovary Syndrome in a Chinese Population. PLoS One (2015) 0.75
Kapalabhati pranayama: An answer to modern day polycystic ovarian syndrome and coexisting metabolic syndrome? Int J Yoga (2016) 0.75
Polycystic ovary syndrome: clinical implication in perimenopause. Prz Menopauzalny (2014) 0.75
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril (2008) 5.31
Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab (2006) 4.56
Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab (2010) 2.48
Effects of two forms of combined oral contraceptives on carbohydrate metabolism in adolescents with polycystic ovary syndrome. Fertil Steril (2006) 2.22
Serum parathyroid hormone concentrations are increased in women with polycystic ovary syndrome. Clin Chem (2005) 1.62
Comparative study of plasma ghrelin levels in women with polycystic ovary syndrome, in hyperandrogenic women and in normal controls. Hum Reprod (2005) 1.43
Exercise and the stress system. Hormones (Athens) (2006) 1.24
Endocrine disruptors and polycystic ovary syndrome (PCOS): elevated serum levels of bisphenol A in women with PCOS. J Clin Endocrinol Metab (2010) 1.24
Cytokine secretion in long-standing diabetes mellitus type 1 and 2: associations with low-grade systemic inflammation. J Clin Immunol (2008) 1.02
Altered D-chiro-inositol urinary clearance in women with polycystic ovary syndrome. Diabetes Care (2006) 1.01
Crosstalk between advanced glycation and endoplasmic reticulum stress: emerging therapeutic targeting for metabolic diseases. J Clin Endocrinol Metab (2012) 1.00
Metformin in polycystic ovary syndrome. Ann N Y Acad Sci (2010) 0.98
Role of androgen excess on metabolic aberrations and cardiovascular risk in women with polycystic ovary syndrome. Womens Health (Lond Engl) (2008) 0.97
Evaluation of serum procalcitonin and interleukin-6 levels as markers of liver metastasis. Clin Biochem (2007) 0.96
Greek hyperinsulinemic women, with or without polycystic ovary syndrome, display altered inositols metabolism. Hum Reprod (2008) 0.95
Liver failure due to antithyroid drugs: report of a case and literature review. Endocrine (2010) 0.92
PCOS Forum: research in polycystic ovary syndrome today and tomorrow. Clin Endocrinol (Oxf) (2011) 0.91
Endothelial function and arterial stiffness in sickle-thalassemia patients. Atherosclerosis (2006) 0.91
The impact of oral contraceptives and metformin on anti-Müllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia. Gynecol Endocrinol (2010) 0.90
Creatine phosphokinase in ectopic pregnancy revisited: significant diagnostic value of its MB and MM isoenzyme fractions. Am J Obstet Gynecol (2006) 0.89
The effects of old, new and emerging medicines on metabolic aberrations in PCOS. Ther Adv Endocrinol Metab (2012) 0.89
Incretin-based therapies for type 2 diabetes mellitus: effects on insulin resistance. Curr Diabetes Rev (2013) 0.89
Critical role of RAGE in lung physiology and tumorigenesis: a potential target of therapeutic intervention? Clin Chem Lab Med (2014) 0.87
Receiver operator characteristics and diagnostic value of progesterone and CA-125 in the prediction of ectopic and abortive intrauterine gestations. Eur J Obstet Gynecol Reprod Biol (2005) 0.87
Lysyl oxidase interacts with AGE signalling to modulate collagen synthesis in polycystic ovarian tissue. J Cell Mol Med (2010) 0.87
The knowledge of osteoporosis risk factors in a Greek female population. Maturitas (2008) 0.86
Phenotypes and enviromental factors: their influence in PCOS. Curr Pharm Des (2012) 0.86
Plasma visfatin levels in normal weight women with polycystic ovary syndrome. Eur J Intern Med (2008) 0.85
Serum luteinizing hormone levels are markedly increased and significantly correlated with Delta 4-androstenedione levels in lean women with polycystic ovary syndrome. Fertil Steril (2005) 0.84
Liver disease in adult transfusion-dependent beta-thalassaemic patients: investigating the role of iron overload and chronic HCV infection. Liver Int (2013) 0.83
Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome. Fertil Steril (2006) 0.83
Plasma B-type natriuretic peptide concentration in beta-thalassaemia patients. Eur J Heart Fail (2007) 0.82
Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome. Endocrine (2012) 0.82
Study of association of IRS-1 and IRS-2 genes polymorphisms with clinical and metabolic features in women with polycystic ovary syndrome. Is there an impact? Gynecol Endocrinol (2010) 0.81
Associations between osteoprotegerin and femoral neck BMD in hemodialysis patients. J Bone Miner Metab (2008) 0.81
Effect of percutaneous endoscopic gastrostomy on gastro-esophageal reflux in mechanically-ventilated patients. World J Gastroenterol (2006) 0.81
Dietary glycotoxins affect scavenger receptor expression and the hormonal profile of female rats. J Endocrinol (2013) 0.80
Early microvascular and macrovascular dysfunction is not accompanied by structural arterial injury in polycystic ovary syndrome. Hormones (Athens) (2006) 0.80
In overweight/obese but not in normal-weight women, polycystic ovary syndrome is associated with elevated liver enzymes compared to controls. Hormones (Athens) (2009) 0.80
Reproductive endocrinology: Infertility treatment in PCOS--is metformin in from the cold? Nat Rev Endocrinol (2012) 0.79
Polycystic ovary syndrome: definitions, phenotypes and diagnostic approach. Front Horm Res (2012) 0.79
Does polycystic ovary syndrome start in childhood? Pediatr Endocrinol Rev (2008) 0.79
Anxiety is associated with hormonal and metabolic profile in women with polycystic ovarian syndrome. Clin Endocrinol (Oxf) (2011) 0.78
Prevalence and impact of hyperandrogenemia in 1,218 women with polycystic ovary syndrome. Endocrine (2014) 0.78
Efficacy of octreotide-LAR in dieting women with abdominal obesity and polycystic ovary syndrome. J Clin Endocrinol Metab (2005) 0.78
Endocrine and metabolic aspects of the Wolfram syndrome. Endocrine (2011) 0.78
The PTHrP/PTH.1-R bioregulation system in cardiac hypertrophy: possible therapeutic implications. In Vivo (2007) 0.78
Decreased active, total and altered active to total ghrelin ratio in normal weight women with the more severe form of polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol (2010) 0.77
Structural, biochemical and non-traditional cardiovascular risk markers in PCOS. Curr Pharm Des (2013) 0.77
Proteomic biomarkers of type 2 diabetes mellitus risk in women with polycystic ovary syndrome. Eur J Endocrinol (2013) 0.77
Mitochondrial Dysfunction and Endoplasmic Reticulum Stress in Diabetes. Curr Pharm Des (2016) 0.76
High Frequency of Thyroid Disorders in Patients Presenting With Neutropenia to an Outpatient Hematology Clinic STROBE-Compliant Article. Medicine (Baltimore) (2015) 0.76
The benefit-to-risk ratio of common treatments in PCOS: effect of oral contraceptives versus metformin on atherogenic markers. Hormones (Athens) (2015) 0.76
Visceral adiposity index (VAI) is related to the severity of anovulation and other clinical features in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) (2014) 0.76
Polycystic ovary syndrome offspring display increased oxidative stress markers comparable to gestational diabetes offspring. Fertil Steril (2012) 0.76
Serum and seminal plasma ghrelin levels in men with normospermia and dyspermia. Gynecol Endocrinol (2008) 0.76
The pluripotential effects of hypolipidemic treatment for polycystic ovary syndrome (PCOS): dyslipidemia, cardiovascular risk factors and beyond. Curr Pharm Des (2011) 0.76
Polycystic ovary syndrome--phenotypes and diagnosis. Scand J Clin Lab Invest Suppl (2014) 0.76
Impact of Androgen and Dietary Advanced Glycation End Products on Female Rat Liver. Cell Physiol Biochem (2015) 0.75
Correlates between hyperinsulinism and hyperandrogenemia? Fertil Steril (2008) 0.75
White blood cells levels and PCOS: direct and indirect relationship with obesity and insulin resistance, but not with hyperandogenemia. Hormones (Athens) (2015) 0.75
Endocrine disruptors and polycystic ovary syndrome: a focus on Bisphenol A and its potential pathophysiological aspects. Horm Mol Biol Clin Investig (2014) 0.75
The effect of oral micronized progesterone on hormonal and metabolic parameters in anovulatory patients with polycystic ovary syndrome. Fertil Steril (2009) 0.75
High incidence of thyroid cancer among patients with acromegaly. J BUON (2016) 0.75
Aging ovary and the role for advanced glycation end products. Menopause (2016) 0.75
The 88th Annual Meeting of the Endocrine Society, June 24-27, 2006, Boston MA, USA: selected pediatric presentations. Pediatr Endocrinol Rev (2008) 0.75
Corrigendum: Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations. Nat Commun (2016) 0.75